Dr Ing Number Of Employees vs. EBITDA

DRPRF Stock  USD 60.93  6.07  9.06%   
Considering the key profitability indicators obtained from Dr Ing's historical financial statements, Dr Ing hc may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Dr Ing's ability to earn profits and add value for shareholders.
For Dr Ing profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Dr Ing to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Dr Ing hc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Dr Ing's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Dr Ing hc over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities.
Please note, there is a significant difference between Dr Ing's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dr Ing is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dr Ing's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Dr Ing hc EBITDA vs. Number Of Employees Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Dr Ing's current stock value. Our valuation model uses many indicators to compare Dr Ing value to that of its competitors to determine the firm's financial worth.
Dr Ing hc is rated # 3 in number of employees category among its peers. It also is rated # 3 in ebitda category among its peers totaling about  256,990  of EBITDA per Number Of Employees. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dr Ing's earnings, one of the primary drivers of an investment's value.

DRPRF Number Of Employees vs. Competition

Dr Ing hc is rated # 3 in number of employees category among its peers. The total workforce of Auto Manufacturers industry is currently estimated at about 245,499. Dr Ing retains roughly 36,519 in number of employees claiming about 15% of stocks in Auto Manufacturers industry.

DRPRF EBITDA vs. Number Of Employees

Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

Dr Ing

Number of Employees

 = 

Full Time

+

Part Time

 = 
36.52 K
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Dr Ing

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
9.38 B
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

DRPRF EBITDA Comparison

Dr Ing is currently under evaluation in ebitda category among its peers.

Dr Ing Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Dr Ing, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Dr Ing will eventually generate negative long term returns. The profitability progress is the general direction of Dr Ing's change in net profit over the period of time. It can combine multiple indicators of Dr Ing, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Porsche AG engages in automotive and financial services businesses. Porsche AG operates as a subsidiary of Porsche Holding Stuttgart GmbH. Dr ING is traded on OTC Exchange in the United States.

DRPRF Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Dr Ing. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Dr Ing position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Dr Ing's important profitability drivers and their relationship over time.

Use Dr Ing in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dr Ing position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dr Ing will appreciate offsetting losses from the drop in the long position's value.

Dr Ing Pair Trading

Dr Ing hc Pair Trading Analysis

The ability to find closely correlated positions to Dr Ing could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dr Ing when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dr Ing - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dr Ing hc to buy it.
The correlation of Dr Ing is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dr Ing moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dr Ing hc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dr Ing can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Dr Ing position

In addition to having Dr Ing in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Large Cap ETFs Thematic Idea Now

Large Cap ETFs
Large Cap ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Large Cap ETFs theme has 674 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Cap ETFs Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in DRPRF Pink Sheet

To fully project Dr Ing's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Dr Ing hc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Dr Ing's income statement, its balance sheet, and the statement of cash flows.
Potential Dr Ing investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Dr Ing investors may work on each financial statement separately, they are all related. The changes in Dr Ing's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Dr Ing's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.